Insider Transactions in Q2 2023 at Ironwood Pharmaceuticals Inc (IRWD)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Julie Mc Hugh |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+12.1%
|
-
|
|
Jun 20
2023
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+15.17%
|
-
|
|
Jun 20
2023
|
Jay Shepard |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+17.94%
|
-
|
|
Jun 20
2023
|
Mark G Currie |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+3.95%
|
-
|
|
Jun 20
2023
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+16.02%
|
-
|
|
Jun 20
2023
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+11.68%
|
-
|
|
Jun 20
2023
|
Jon R Duane |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+16.38%
|
-
|
|
Jun 20
2023
|
Marla L Kessler |
BUY
Grant, award, or other acquisition
|
Direct |
22,350
+17.35%
|
-
|
|
Jun 15
2023
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+1.41%
|
-
|
|
Jun 15
2023
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
1,586
+1.52%
|
-
|
|
May 30
2023
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,632
-3.39%
|
$266,320
$10.7 P/Share
|
|
May 22
2023
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,000
-4.39%
|
$360,000
$10.12 P/Share
|
|
May 22
2023
|
Andrew Davis SVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
6,305
-2.79%
|
$63,050
$10.12 P/Share
|
|
May 22
2023
|
Michael Shetzline CMO,SVP,Head-Res&Drug |
SELL
Open market or private sale
|
Direct |
10,324
-3.11%
|
$103,240
$10.12 P/Share
|
|
May 08
2023
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,148
-2.51%
|
$211,480
$10.62 P/Share
|